3-Indolepropionic Acid (IPA) CAS 830-96-6 Tsarkake> 99.5% (HPLC) Hoton Babban Ingancin Factory

3-Indolepropionic Acid (IPA) CAS 830-96-6 Tsarkake> 99.5% (HPLC) Babban Ingancin Factory

Takaitaccen Bayani:

Sunan Kemikal: 3-Indolepropionic Acid (IPA)

Saukewa: 830-96-6

Tsafta:> 99.5% (HPLC)

Bayyanar: Kashe-Fara zuwa Hasken Foda ko Lu'ulu'u

Kyakkyawan inganci, Samar da Kasuwanci

E-Mail: alvin@ruifuchem.com

Aika mana imel

Cikakken Bayani

Samfura masu dangantaka

Tags samfurin

Bayani:

Shanghai Ruifu Chemical Co., Ltd. shine babban masana'anta kuma mai ba da 3-Indolepropionic Acid (IPA) (CAS: 830-96-6) tare da inganci mai inganci, samar da kasuwanci.Maraba don yin oda.

Abubuwan Sinadarai:

Sunan Sinadari	3-Indolepropionic Acid
Makamantu	IPA;3- (1H-indol-3-yl) propanoic acid;3- (1H-indol-3-yl) -propionic acid;3- (3-Indolyl) propanoic acid;3- (3-Indolyl) propionic acid
Lambar CAS	830-96-6
Lambar CAT	Saukewa: RF-PI1540
Matsayin Hannun jari	A cikin Hannun jari, Ma'aunin samarwa Har zuwa Ton
Tsarin kwayoyin halitta	Saukewa: C11H11NO2
Nauyin Kwayoyin Halitta	189.21
Solubility a cikin methanol	Tashin hankali sosai
Wurin Tafasa	82 ℃ (lit.)
Yawan yawa	0.960 g/ml a 20 ℃
Alamar	Ruifu Chemical

Ƙayyadaddun bayanai:

Abu	Ƙayyadaddun bayanai
Bayyanar	Kashe-Fara zuwa Hasken Foda ko Lu'ulu'u
Tsarkake / Hanyar Bincike	> 99.5% (HPLC)
Matsayin narkewa	130.0 ~ 136.0 ℃
Danshi (na Karl Fischer)	<0.50%
Rashin Tsabtace Guda Daya	<0.50%
Jimlar ƙazanta	<0.50%
1 H NMR Spectrum	Daidaita Da Tsarin
Matsayin Gwaji	Matsayin Kasuwanci
Amfani	Matsakaicin Magunguna

Kunshin & Ajiya:

Kunshin: Bottle, Aluminum tsare jakar, 25kg / Kwali Drum, ko bisa ga abokin ciniki ta bukata.

Yanayin Ajiya:Ajiye a cikin kwantena da aka rufe a wuri mai sanyi da bushe;Kare daga haske da danshi.

Amfani:

FAQ:

Aikace-aikace:

3-Indolepropionic Acid (IPA) (CAS: 830-96-6), Mai amsawa don shirye-shiryen: Fluorescent analogues na strigolactones;Magungunan rigakafi;Melanocortin ligands masu karɓa;Magungunan rigakafi;Masu hana cutar hepatitis C;Histamine H4 agonists masu karɓa;NR2B/NMDA antagonists mai karɓa;CB1 antagonist don maganin kiba;Magungunan rigakafi;Mai hana TGF-β mai ɗaurin mai karɓa.